Initial commit

This commit is contained in:
Zhongwei Li
2025-11-30 08:30:18 +08:00
commit 74bee324ab
335 changed files with 147377 additions and 0 deletions

View File

@@ -0,0 +1,318 @@
# Radiology Report Template
## Patient Information
**Patient Name:** [Last, First]
**Medical Record Number:** [MRN]
**Date of Birth:** [MM/DD/YYYY]
**Age:** [years]
**Sex:** [M/F]
**Exam Date:** [MM/DD/YYYY]
**Exam Time:** [HH:MM]
**Accession Number:** [Number]
**Referring Physician:** [Name]
**Ordering Service:** [Service/Department]
---
## Examination
**Exam Type:** [CT/MRI/X-Ray/Ultrasound/PET/Nuclear Medicine scan]
**Body Part:** [Anatomical region - e.g., Chest, Abdomen and Pelvis, Brain]
**Contrast:** [Yes - IV/Oral/Both | No]
**Laterality:** [Right/Left/Bilateral if applicable]
---
## Clinical Indication
[Reason for examination, relevant clinical history, specific question to be answered]
Example: "Rule out pulmonary embolism in patient with acute dyspnea and chest pain. History of recent surgery."
---
## Comparison
**Prior Studies:**
[Modality] of [body part] from [date]: [Available/Not available for comparison]
Example: "CT chest without contrast from 6 months prior (01/15/2023) available for comparison"
OR: "No prior imaging available for comparison"
---
## Technique
[Detailed description of imaging parameters and protocol]
**For CT:**
```
Multidetector CT of the [body region] was performed [without/with] intravenous
contrast. [Volume] mL of [iodinated contrast agent name] was administered
intravenously. Images were acquired in the [arterial/venous/delayed] phase(s).
Multiplanar reconstructions were performed.
Technical quality: [Adequate / Limited by motion artifact / Limited by patient body habitus]
Radiation dose (DLP): [mGy-cm]
```
**For MRI:**
```
MRI of the [body region] was performed [without/with] intravenous contrast
using the following sequences: [list sequences - T1, T2, FLAIR, DWI, etc.]
[Volume] mL of [gadolinium-based contrast agent] was administered intravenously.
Multiplanar imaging was obtained.
Technical quality: [Adequate / Limited by motion artifact]
```
**For X-Ray:**
```
[Number] views of the [body part] were obtained: [AP/PA/Lateral/Oblique]
Technical quality: [Adequate penetration and positioning / Limited by...]
```
**For Ultrasound:**
```
Real-time ultrasound examination of the [body part] was performed using
[linear/curved] array transducer.
Technical quality: [Adequate / Limited by bowel gas / Limited by body habitus]
```
---
## Findings
[Systematic, comprehensive description of findings organized by anatomical region or organ system]
### [Region/Organ 1]
[Detailed findings - size, density/intensity, enhancement pattern, abnormalities]
**Normal statement:** "[Organ] is normal in size, contour, and [attenuation/signal intensity]. No focal lesions."
**Abnormal statement:** "[Description of abnormality with measurements]"
Example:
```
Lungs:
- Bilateral ground-glass opacities are present, predominant in the lower lobes.
- Right lower lobe consolidation measuring 4.5 x 3.2 cm with air bronchograms.
- No pleural effusion or pneumothorax.
- Airways are patent bilaterally.
```
### [Region/Organ 2]
[Findings]
### [Additional Regions as Applicable]
**For Chest CT:**
- Lungs
- Airways
- Pleura
- Mediastinum and Hila
- Heart and Great Vessels
- Chest Wall
- Upper Abdomen (if included)
- Bones
**For Abdomen/Pelvis CT:**
- Liver
- Gallbladder
- Spleen
- Pancreas
- Kidneys and Adrenals
- Gastrointestinal Tract
- Peritoneum and Mesentery
- Retroperitoneum
- Bladder
- Pelvic Organs
- Vasculature
- Lymph Nodes
- Bones
- Soft Tissues
**For Brain MRI:**
- Brain Parenchyma
- Ventricles and Cisterns
- Extra-axial Spaces
- Vascular Structures
- Orbits (if included)
- Skull Base and Calvarium
### Measurements (if applicable)
| Structure | Measurement | Normal Range |
|-----------|-------------|--------------|
| [Lesion/mass] | [Size in cm, 3 dimensions] | - |
| [Organ] | [Size] | [Normal size] |
---
## Impression
[Concise summary of key findings with clinical interpretation]
**Format as numbered list in order of clinical importance:**
1. **[Most important finding]** - [Diagnosis or differential, clinical significance]
- [Additional details, comparison to prior if applicable]
- [Recommendation if any]
2. **[Second finding]** - [Interpretation]
3. **[Additional findings]**
**Alternative format for normal study:**
```
No acute intrathoracic abnormality.
Specifically, no evidence of pulmonary embolism.
```
**Recommendations (if applicable):**
- [Further imaging, follow-up imaging interval, clinical correlation, biopsy, etc.]
- [Timeframe for follow-up]
Example:
```
Recommend follow-up CT in 3 months to assess for interval change.
Clinical correlation with laboratory values recommended.
Consider PET/CT for further characterization if clinically indicated.
```
---
## Communication of Critical Results
[If critical/urgent finding]
**Critical finding:** [Description]
**Communicated to:** [Name and role of person notified]
**Date/Time:** [MM/DD/YYYY at HH:MM]
**Method:** [Phone call / Page / In person]
**Read back verified:** [Yes]
---
## Structured Reporting (if applicable)
### For Lung Nodules (Lung-RADS):
**Category:** [Lung-RADS 0/1/2/3/4A/4B/4X]
**Recommendation:** [Per Lung-RADS guidelines]
### For Breast Imaging (BI-RADS):
**Category:** [BI-RADS 0/1/2/3/4/5/6]
**Recommendation:** [Per BI-RADS guidelines]
### For Liver Lesions (LI-RADS):
**Category:** [LI-RADS 1/2/3/4/5/M/TIV]
**Features:** [Arterial phase hyperenhancement, washout, capsule, size, growth]
### For Prostate (PI-RADS):
**Score:** [PI-RADS 1/2/3/4/5]
**Location:** [Peripheral zone / Transition zone]
---
## Signature
**Interpreted by:**
[Radiologist name, MD]
[Board certification]
[NPI number if required]
**Electronically signed:** [Date and time]
**Dictated:** [Date and time]
**Transcribed:** [Date and time]
**Signed:** [Date and time]
---
## Template Notes
### General Principles
**Be systematic:**
- Use consistent order (head to toe, outside to inside)
- Don't skip regions even if normal
- Include pertinent negatives
**Be specific:**
- Provide measurements (size in 3 dimensions for masses)
- Describe location precisely
- Use standardized terminology (RadLex)
- Quantify when possible
**Be clear:**
- Avoid ambiguous language
- Make impression stand-alone
- Answer the clinical question directly
- State what IS present, not just what isn't
**Communication:**
- Critical findings require immediate verbal notification
- Document communication
- Provide specific recommendations
- Suggest next steps when appropriate
### Measurement Guidelines
**Lesions/Masses:**
- Three dimensions: [length x width x height in cm]
- Use consistent measurement method for follow-up
**Lymph Nodes:**
- Short axis diameter in cm
- Note morphology (round vs. oval)
**Organ Sizes:**
- Use established normal ranges
- Age and sex appropriate
### Comparison Statements
**Improved:**
"Interval decrease in size of right upper lobe mass from 3.5 cm to 2.1 cm."
**Stable:**
"Unchanged 8 mm left lower lobe nodule, stable for 2 years."
**Worsened:**
"Interval increase in bilateral pleural effusions, now moderate on the right."
**New finding:**
"New 1.5 cm right adrenal nodule, not present on prior CT."
### Differential Diagnosis Language
**Definite:** "Consistent with..."
**Probable:** "Most likely represents..." or "Favors..."
**Possible:** "Suggestive of..." or "Differential diagnosis includes..."
**Uncertain:** "Cannot exclude..." or "Consider..."
### Recommendations
**Follow-up imaging:**
- Specify modality, timing, and what to assess
- "Recommend CT chest in 6-12 months to assess stability"
**Further characterization:**
- "Consider MRI for further characterization"
- "Ultrasound correlation recommended"
**Clinical correlation:**
- "Clinical correlation with tumor markers recommended"
- "Correlate with patient symptoms and physical examination"
**Biopsy/Intervention:**
- "Consider biopsy for definitive diagnosis"
- "Amenable to image-guided biopsy if clinically indicated"